Literature DB >> 29886

Chymotrypsin inhibitors from hemolymph of the silkworm, Bombyx mori.

T Sasaki.   

Abstract

Three new protease inhibitors were isolated and purified about 200-fold from hemolymph of silkworm larvae, Bombyx mori, using ion-exchange and affinity chromatography. Two of the three inhibitors were basic proteins (SCI-I had pI 9.4 and SCI-II had pI 9.6) and one was acidic (SCI-III had pI 4.0). The molecular weight of each inhibitor was determined to be 7,000 by the sedimentation equilibrium method. The amino acid composition of the inhibitors were similar except for the contents of Asp, Glu, Ile, Leu, and Lys. Val, His, and Trp were not present in the inhibitors and Met appeared only in SCI-III. The CD spectra of the inhibitors were all similar and indicated a low content of alpha-helical structure (10% at most). Each inhibitor could inhibit the protease and esterase activities of bovine alpha-chymotrypsin at a one-to-one molar ratio, and the dissociation constants were 3.1 X 10(-9)M for SCI-I and II and 1.3 X 10(-8)M for SCI-III. Only SCI-II showed a weak inhibitory activity against bovine trypsin. Subtilisin BPN' and papain were not inhibited by these inhibitors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29886     DOI: 10.1093/oxfordjournals.jbchem.a132127

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  4 in total

1.  Purification and characterization of a high-Mr proteinase inhibitor of pro-phenol oxidase activation from crayfish plasma.

Authors:  H G Hergenhahn; A Aspan; K Söderhäll
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

2.  Genetic variants of protease inhibitors against fungal protease and alpha-chymotrypsin from hemolymph of the silkworm, Bombyx mori.

Authors:  M Eguchi; K Ueda; M Yamashita
Journal:  Biochem Genet       Date:  1984-12       Impact factor: 1.890

3.  Purification, characterization and cloning of a chymotrypsin inhibitor (CI-9) from the hemolymph of the silkworm, Bombyx mori.

Authors:  Ping Zhao; Qingyou Xia; Juan Li; Hiroshi Fujii; Yutaka Banno; Zhonghuai Xiang
Journal:  Protein J       Date:  2007-08       Impact factor: 2.371

4.  Bioavailability of orally administered rhGM-CSF: a single-dose, randomized, open-label, two-period crossover trial.

Authors:  Wenping Zhang; Zhengbing Lv; Zuoming Nie; Guogang Chen; Jian Chen; Qing Sheng; Wei Yu; Yongfeng Jin; Xiangfu Wu; Yaozhou Zhang
Journal:  PLoS One       Date:  2009-05-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.